Highbridge Capital Management’s Kite Pharma, Inc. KITE Stock Holding History

Highbridge Capital Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,400	Closed	-$792K	–	2199
2017 Q3	$792K	Buy	4,400 +1,100	+33%	+$153K	0.01%	697
2017 Q2	$341K	Sell	3,300 -2,600	-44%	-$212K	0.01%	920
2017 Q1	$463K	Buy	+5,900	New	+$365K	0.01%	936
2015 Q3	–	Sell	-16,600	Closed	-$1.01M	–	1984
2015 Q2	$1.01M	Sell	16,600 -39,300	-70%	-$2.24M	0.01%	727
2015 Q1	$3.22M	Buy	55,900 +41,100	+278%	+$2.75M	0.04%	416
2014 Q4	$854K	Buy	+14,800	New	+$623K	0.01%	690

Highbridge Capital Management's KITE Position: Q1 2016 in Review

Highbridge Capital Management sold out of Kite Pharma, Inc. (KITE) in Q1 2016, closing a stake of 7,725 shares — an estimated $476K sold.

Highbridge Capital Management first reported a position in KITE in Q4 2015 and held it in 1 quarter. The position peaked at $476K in Q4 2015. 171 funds tracked by Wall St. Rank hold KITE as of Q1 2016.

Highbridge Capital Management reported no remaining Kite Pharma, Inc. position as of Q1 2016 after selling out during the quarter.
Highbridge Capital Management sold 7,725 Kite Pharma, Inc. shares in Q1 2016, an estimated $476K.
Highbridge Capital Management first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 1 quarter.
Highbridge Capital Management's Kite Pharma, Inc. position peaked at $476K in Q4 2015.
171 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2016.

Based on Highbridge Capital Management's 13F filing for Q1 2016, filed 16 May 2016.